Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticlePractical Protocol Tip

Gated Myocardial Perfusion Imaging

Maria L. Mackin
Journal of Nuclear Medicine Technology June 2020, 48 (2) 139-140; DOI: https://doi.org/10.2967/jnmt.120.245035
Maria L. Mackin
CNMT, RT(N)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

RATIONALE

Electrocardiographic gating enhances the diagnostic and prognostic capability of myocardial perfusion imaging and provides incremental information over perfusion data alone in patients with known or suspected coronary artery disease. Gated myocardial perfusion imaging allows assessment and quantification of the global and regional function of the left ventricle. Quantitation of ventricular function includes end-diastolic volume (EDV), end-systolic volume (ESV), systolic volume (EDV – ESV), ejection fraction ([EDV – ESV]/EDV × 100%), wall motion, wall thickening, diastolic function, phase analysis, peak filling rate, and time that peak ejection rate occurs.

INDICATIONS

Gated myocardial perfusion imaging is indicated for detection of coronary artery disease in patients with an intermediate pretest probability or high coronary risk factors, for risk stratification after myocardial infarction, and for evaluation of the efficacy of drug therapy or revascularization. The indication for the myocardial perfusion imaging study should meet the appropriate use criteria for cardiac radionuclide imaging. If the patient history does not meet these criteria, the interpreting or ordering physician should be contacted for verification (5).

CONTRAINDICATIONS

Contraindications include pregnancy, breast-feeding, or a recent nuclear medicine study (radiopharmaceutical-dependent). Pregnancy must be excluded in accordance with the local institutional policy. If the patient is breast-feeding, radiation safety instructions should be provided.

PATIENT PREPARATION

Instruct patients to wear comfortable clothing; to fast for 4 h before the test; to refrain from taking any caffeine, decaffeinated products, or nicotine for at least 12 h before the test (in the event the patient cannot perform an adequate stress test and is switched to a pharmacologic stress test); and to bring a list of all their medications. Caffeine-containing items include coffee, tea, cola, hot cocoa, Excedrin (GlaxoSmithKline), Sunkist orange soda (Cadbury Schweppes), energy drinks, decaffeinated coffee, herbal tea, decaffeinated soda, chocolate, No-Doz (Lil’ Drug Store Products, Inc.), and Anacin (Prestige Consumer Healthcare Inc.). With the agreement of the patient’s physician, β-blockers, calcium channel blockers, and nitrates should discontinued for 48 h before the test, and nitroglycerine should be discontinued for 4–6 h. Aminophylline, theophylline, Aggrenox (Boehringer Ingelheim), Persantine (Boehringer Ingelheim), and dipyridamole should be discontinued for 48 h before a pharmacologic stress test. Other medications may be withheld or given at the discretion of the ordering physician. Instruct diabetic patients to refrain from taking oral diabetic medication or insulin the morning of the test and to take half the usual dose of insulin the evening before the test.

ACQUISITION

Before the acquisition, obtain a focused history that includes the indication for the test, medications, symptoms, cardiac risk factors, history of past and current diseases, and history of interventional or surgical procedures. Table 1 summarizes the radiopharmaceutical identity, dose, and route of administration, and Table 2 summarizes the acquisition parameters. Because myocardial perfusion imaging is a comparative study, try to acquire rest and stress SPECT studies in same fashion (e.g., same patient position and radius).

  1. Inject patient with 201Tl or the low dose of either 99mTc-tetrofosmin or 99mTc-sestamibi at rest.

  2. Acquire SPECT rest study at 30 min (for 99mTc-tetrofosmin), at 45 min (for 99mTc-sestamibi), or at 20 min (for 201Tl) after injection.

  3. Place 3 electrocardiography electrodes on patient’s chest, and attach electrocardiography wires (white on right upper chest, black on left upper chest, and red on left lower abdomen). In patients with peaked T waves, move electrodes to prevent double counting. Usually, moving red electrode toward patient’s back will solve this issue.

  4. Place patient supine with either left arm or both arms over head and out of field of view. If patient cannot raise arms, arms-down imaging can be performed.

  5. On 90°-configured dual-head camera, use starting gantry position of 0° (head 1 at 45° right anterior oblique, head 2 at 45° left anterior oblique). On single-head camera, use starting angle of 45° right anterior oblique.

  6. Place heart as close as possible to center of field of view. Position camera heads as close as possible to patient and table to obtain 180° acquisition.

  7. Make patients as comfortable as possible, explain to them the importance of holding still, and tell them how long the acquisition will take.

  8. To avoid artifacts, make sure counts in heart appear as hot as those in liver. There should be no bowel activity interfering with visualization of heart. Imaging should be delayed to allow for adequate liver and bowel clearance, if necessary.

  9. Review raw data as a cine projection before moving patient to evaluate quality of acquisition, noting potential artifacts such as poor counts, dropped frames, patient motion, or attenuation. Repeat imaging in the event of significant artifacts.

  10. Inject patient with high-dose 99mTc-tetrofosmin or 99mTc-sestamibi at peak exercise or peak coronary vasodilatation.

  11. Acquire SPECT stress study with electrocardiography gating after patient adequately recovers from exercise (minimum, 15 min). After injection of pharmacologic stress, wait 30–45 min to begin imaging.

  12. Review raw data as a cine projection before moving patient to evaluate quality of acquisition, noting potential artifacts such as poor counts, dropped frames, patient motion, or attenuation. Repeat imaging in the event of significant artifacts.

View this table:
  • View inline
  • View popup
TABLE 1

Radiopharmaceutical Identity, Dose, and Route of Administration

View this table:
  • View inline
  • View popup
TABLE 2

SPECT Acquisition Parameters

PROCESSING

  1. Process SPECT images per manufacturer’s recommendation and interpreting physician’s preference, including preprocessing, attenuation correction, motion correction, reconstruction, and filter selection (filtered backprojection or iterative).

  2. Reconstruct images into short-axis, vertical long-axis, and horizontal long-axis views.

  3. Align perfusion and viability slices so that slices match same sections of myocardium. Display short-axis slices from apex to base. For vertical long-axis slices, point apex toward left of image. For horizontal long-axis slices, point apex up.

  4. Normalize images to hottest pixel in each slice.

  5. Display normalized slices and other quantification images such as polar plot, left ventricular volume curve, and summed stress–rest scores.

REFERENCES

  1. 1.
    1. Johnson SG,
    2. Farrell MB,
    3. Alessi AM,
    4. Hyun MD
    , eds. NCT Study Guide for Technologists. 2nd ed. Reston, VA: SNMMI; 2015.
  2. 2.
    1. Paul AK,
    2. Nabi HA
    . Gated myocardial perfusion SPECT: basic principles, technical aspects and clinical applications. J Nucl Med Technol. 2004;32:179–189.
    OpenUrlAbstract/FREE Full Text
  3. 3.
    1. Waterstram-Rich K,
    2. Gillmore D
    . Nuclear Medicine and PET/CT Technology and Techniques. 8th ed. St Louis, MO: Elsevier; 2017.
  4. 4.
    1. Henzlova MJ,
    2. Duvall WL,
    3. Einstein AJ,
    4. et al
    . ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016;22:606–639.
    OpenUrl
  5. 5.
    1. Hendel RC,
    2. Berman DS,
    3. Di Carli MF,
    4. et al
    . 2009 appropriate use criteria for cardiac radionuclide imaging. J Am Coll Cardiol. 2009;53:2201–2229.
    OpenUrlFREE Full Text
  6. 6.
    1. Holly TA,
    2. Abbott BG,
    3. Al-Mallah M,
    4. et al
    . ASNC Imaging Guidelines for Nuclear Cardiology Procedures: Single Photon-Emission Computed Tomography. Fairfax, VA: American Society of Nuclear Cardiology; 2010
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 48 (2)
Journal of Nuclear Medicine Technology
Vol. 48, Issue 2
June 1, 2020
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Gated Myocardial Perfusion Imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Gated Myocardial Perfusion Imaging
Maria L. Mackin
Journal of Nuclear Medicine Technology Jun 2020, 48 (2) 139-140; DOI: 10.2967/jnmt.120.245035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Gated Myocardial Perfusion Imaging
Maria L. Mackin
Journal of Nuclear Medicine Technology Jun 2020, 48 (2) 139-140; DOI: 10.2967/jnmt.120.245035
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • RATIONALE
    • INDICATIONS
    • CONTRAINDICATIONS
    • PATIENT PREPARATION
    • ACQUISITION
    • PROCESSING
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Fatty Meal Hepatobiliary Scintigraphy for Gallbladder Ejection Fraction Determination
  • Gastric Emptying Study: Liquids
  • Ventricular Shunt Patency
Show more Practical Protocol Tip

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire